Taro Pharmaceutical Industries stock gains cash merger payout at USD 32.25 per share

Published on 09/21/2026 at 23:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Taro Pharmaceutical Industries stock is being retired in a cash merger at USD 32.25 per share, according to a corporate action note dated September 21, 2026. The deal values existing shares at a fixed cash consideration and closes out the listing for investors.

TARO, US8764881063, Illustration mit AI erstellt.

Taro Pharmaceutical Industries stock (ISIN US8764881063) is in the final stages of a cash merger that will see existing shareholders receive USD 32.25 per share in cash, according to a corporate actions update dated September 21, 2026.

Cash merger terms fix exit price

According to Robinhood, Taro Pharmaceutical Industries Ltd. (ticker TARO) has performed a cash merger in which shares are removed and shareholders will receive USD 32.25 per share in cash.

This fixed cash consideration of USD 32.25 per share effectively sets the terminal value for Taro Pharmaceutical Industries stock as the company is taken private, closing out upside and downside beyond the agreed merger price as of late September 2026.

Deal valuation and investor perspective

The merger payout of USD 32.25 per share provides a concrete valuation benchmark for Taro Pharmaceutical Industries, translating directly into the cash amount investors will receive for each share they hold once the transaction is completed.

For investors, the key comparison is between the USD 32.25 per-share cash payment and Taro Pharmaceutical Industries stock levels seen in the months leading up to the merger announcement, as the agreed price represents the premium that dealmakers were willing to pay to secure control of the business.

Stock exit price and trading venue

With the cash merger in place, Taro Pharmaceutical Industries stock is being removed from its primary Nasdaq listing, and the USD 32.25 per share payout now functions as the effective exit price for investors as of September 21, 2026.